Deutsche Bank’s Biogen BIIB Stock Holding History

Deutsche Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-337	Closed	-$78K	–	4889
2019 Q2	$78K	Buy	337 +292	+649%	+$67.4K	﹤0.01%	4324
2019 Q1	$10K	Sell	45 -299	-87%	-$94.2K	﹤0.01%	4916
2018 Q4	$103K	Sell	344 -136	-28%	-$43.4K	﹤0.01%	4209
2018 Q3	$170K	Hold	480	–	–	﹤0.01%	4301
2018 Q2	$139K	Buy	480 +91	+23%	+$25.6K	﹤0.01%	4425
2018 Q1	$106K	Buy	+389	New	+$121K	﹤0.01%	4472
2017 Q2	–	Sell	-14	Closed	-$3K	–	4931
2017 Q1	$3K	Sell	14 -466	-97%	-$132K	﹤0.01%	4741
2016 Q4	$135K	Buy	480 +80	+20%	+$23.7K	﹤0.01%	3916
2016 Q3	$125K	Hold	400	–	–	﹤0.01%	3857
2016 Q2	$96K	Hold	400	–	–	﹤0.01%	4134
2016 Q1	$104K	Buy	400 +310	+344%	+$81.9K	﹤0.01%	3993
2015 Q4	$27K	Hold	90	–	–	﹤0.01%	4651
2015 Q3	$26K	Hold	90	–	–	﹤0.01%	4697
2015 Q2	$36K	Hold	90	–	–	﹤0.01%	4719
2015 Q1	$38K	Hold	90	–	–	﹤0.01%	4467
2014 Q4	$30K	Hold	90	–	–	﹤0.01%	5369
2014 Q3	$29K	Buy	+90	New	+$29.7K	﹤0.01%	5076

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank's BIIB Position: Q1 2026 in Review

Deutsche Bank increased its Biogen (BIIB) stake by 12% in Q1 2026, buying an estimated $20.3M and bringing the position to 1,063,828 shares worth $195M. The position accounts for 0.06% of the portfolio, ranked #283.

Deutsche Bank first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $963M in Q1 2018. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Deutsche Bank held 1,063,828 shares of Biogen worth $195M as of Q1 2026.
Deutsche Bank bought 110,100 Biogen shares in Q1 2026, an estimated $20.3M.
Biogen made up 0.06% of Deutsche Bank's portfolio in Q1 2026, its #283 holding.
Deutsche Bank first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
Deutsche Bank's Biogen position peaked at $963M in Q1 2018.
1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.